That is interesting, I'm learning a lot from this virus for sure. The big thing Covid has done for Leronlimab is to show the MOA of the drug in a disease far different than HIV. It is amazing to see how mainstream media now knows and talks about the Cytokine storm etc..

I've often wondered if withing the 800+ trial participants in the HIV trials we have learned about Leronlimab's MOA in issues other than just HIV. Some of these patients have NASH, MS, got the flu etc.. I wonder if the side effect of Leronlimab has uncovered details of some of these diseases we did not know before and/or Leronlimab's influence on them.